About BridgeBio Pharma (BBIO)
BridgeBio Pharma, Inc. is a United States-based company, The Company discovers and develops medicines that target well-characterized genetic diseases. The Company’s product platform divided into three key categories: Mendelian, Oncology and Gene ther... Read more
- USD24.88
- USD25.36
- USD24.27
- USD44.32
- -13.00%
- 9M
- 2.30M
- 1.58M
- 4.9B
- 12.75
- 48.30%
Stock News
1 hour ago
Reed Hastings shares the 3-word tactic that helped make Netflix a $240 billion company—it's called 'farming for dissent'
CNBC
1 hour ago
S&P 500 Giants, Leading AI Play Among 5 Stocks To Watch In Tough Market
Yahoo
1 hour ago
If you’re investing in the AI theme for the long haul, here’s how to pick the winners
CNBC
1 hour ago
Why the oil market shrugged as Iran and Israel appeared on the brink of war this week
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
